Molecules · 2020 · 65 citations · 49 references
PharmacyInfectious DiseasesPharmacologyDrug DesignDrug DiscoveryVirologyComputational Drug DiscoveryComputational Drug RepurposingMolecular DockingProtein-ligand DockingStructure-based RepurposingVirtual ScreeningHigh-throughput Virtual ScreeningMolecular Docking AnalysisMolecular Docking Of InhibitorsProtein-protein Interaction Inhibitor DiscoverySars-cov-2 InfectionTarget-based Drug RepurposingViral Replication ControlVirtual Screening Space
The SARS-CoV-2 outbreak caused an unprecedented global public health threat, having a high transmission rate with currently no drugs or vaccines approved. An alternative powerful additional approach to counteract COVID-19 is in silico drug repurposing. The SARS-CoV-2 main protease is essential for viral replication and an attractive drug target. In this study, we used the virtual screening protocol with both long-range and short-range interactions to select candidate SARS-CoV-2 main protease inhibitors. First, the Informational spectrum method applied for small molecules was used for searching the Drugbank database and further followed by molecular docking. After in silico screening of drug space, we identified 57 drugs as potential SARS-CoV-2 main protease inhibitors that we propose for further experimental testing.
49
DrugBank 5.0: a major update to the DrugBank database for 2018
David S. Wishart, Yannick Djoumbou-Feunang, An Chi Guo et al. · Nucleic Acids Research · 2017 · 8.8K citations · Full text
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin, Xiaoyu Du, Yechun Xu et al. · Nature · 2020 · 4.5K citations · Full text
Small-Molecule Library Screening by Docking with PyRx
Sargis Dallakyan, Arthur J. Olson · Methods in molecular biology · 2014 · 3.9K citations